Key Applications

• Pathogenesis Investigation:​ Uncovering the molecular and cellular mechanisms by which a specific genetic defect leads to disease pathology.

• Therapeutic Target Validation:​ Confirming that modulating a specific biological pathway can alter disease progression.

• Drug Efficacy and Safety Testing:​ Providing robust preclinical data on pharmacokinetics, biodistribution, and potential toxicity of novel therapies, including small molecules, biologics, and gene therapies.

• Biomarker Discovery:​ Identifying and validating measurable indicators for tracking disease progression and treatment response.

Common Model Types

• Knockout (KO) Models:​ Mimic loss-of-function mutations seen in diseases like Spinal Muscular Atrophy (SMA) or Duchenne Muscular Dystrophy (DMD).

• Knock-in (KI) Models:​ Precisely introduce a specific human point mutation or trinucleotide repeat expansion, as used in models of Huntington's disease or Rett syndrome.

• Humanized Models:​ Replace the mouse gene with its human counterpart to study human-specific disease pathways or test therapies targeting the human protein.

Advantages and Impact

These models offer high genetic precision, the ability to control environmental variables, and the opportunity to perform longitudinal studies not feasible in patients. They have become a cornerstone for orphan drug development, helping to de-risk clinical programs and bring life-changing treatments to market for conditions that were once considered untreatable.